{"id":510164,"date":"2021-07-07T08:03:16","date_gmt":"2021-07-07T12:03:16","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/aditxt-opens-its-first-high-capacity-immune-monitoring-center-in-richmond-va\/"},"modified":"2021-07-07T08:03:16","modified_gmt":"2021-07-07T12:03:16","slug":"aditxt-opens-its-first-high-capacity-immune-monitoring-center-in-richmond-va","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/aditxt-opens-its-first-high-capacity-immune-monitoring-center-in-richmond-va\/","title":{"rendered":"Aditxt Opens its First High-Capacity Immune Monitoring Center in Richmond, VA"},"content":{"rendered":"<p>        <!--.bwalignc { text-align: center; list-style-position: inside }\n.bwuline { text-decoration: underline }body {font:normal small Arial,Helvetica,sans-serif;color:#000;background-color:#fff;padding:24px;margin:0;} a img {border:0;} h3 {font-size:medium;color:#000;margin:0 0 1em 0; text-align:center;}-->  <\/p>\n<p class=\"bwalignc\"><b>Aditxt Opens its First High-Capacity Immune Monitoring Center in Richmond, VA<\/b><\/p>\n<p class=\"bwalignc\">\nAditxtScore<sup>TM <\/sup>Center to Become Global Headquarters for Aditxt as a Biotech Innovator Focused on Immune Health\n<\/p>\n<p>RICHMOND, Va.&#8211;(<a href=\"http:\/\/www.businesswire.com\">BUSINESS WIRE<\/a>)&#8211;<a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Faditxt.com%2F&amp;esheet=52456046&amp;newsitemid=20210707005221&amp;lan=en-US&amp;anchor=Aditxt%2C+Inc.&amp;index=1&amp;md5=3a2f74ec4af7d32b91f172fa8eead73e\">Aditxt, Inc.<\/a> (Nasdaq: ADTX), a biotech innovation company with a mission to improve the health of the immune system, today announced the opening of its AditxtScore\u2122 Center in Richmond, VA. This high-capacity, CLIA-validated immune monitoring center will be scalable to process several million complex immune system reports per year.\n<\/p>\n<p>\n\u201cThe opening of the AditxtScore Center is a key step on AditxtScore\u2019s path to market, serving as a critical enabler to commercializing a new platform for personalized health,\u201d said Amro Albanna, Co-founder and Chief Executive Officer of Aditxt. \u201cIn addition to its operational and commercial capabilities, this facility will also help accelerate new AditxtScore application development activities to address markets with significant growth potential.\u201d\n<\/p>\n<p>\nIntroduced earlier this year in a <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.prnewswire.com%2Fnews-releases%2Faditxt-to-establish-state-of-the-art-immune-monitoring-center-in-richmond-va-301282382.html&amp;esheet=52456046&amp;newsitemid=20210707005221&amp;lan=en-US&amp;anchor=joint+press+conference&amp;index=2&amp;md5=5e5d2c037fbe90f26b3f90c8e0d4d163\">joint press conference<\/a> including Governor Ralph Northam and Richmond Mayor Levar Stoney, the AditxtScore Center was built to support the growth of the AditxtScore platform, a pioneering new approach to immune and health monitoring that provides a personalized profile of the immune system. By assessing an individual&#8217;s immune biomarkers, AditxtScore is designed to measure indications of immune response to specific disease. AditxtScore applications include the recently commercialized AditxtScore for COVID-19, developed for use in detecting antibodies against SARS-CoV-2 antigens.\n<\/p>\n<p>\nAditxtScore is offered through authorized channel partners. To find an AditxtScore Channel Partner near you, please visit <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.aditxtscore.com&amp;esheet=52456046&amp;newsitemid=20210707005221&amp;lan=en-US&amp;anchor=www.aditxtscore.com&amp;index=3&amp;md5=d91bdede242c4d073002f0bc7b612d8b\">www.aditxtscore.com<\/a>. AditxtScore is available for use as a CLIA-validated laboratory developed test (LDT). This test is not for self-diagnosis and is not cleared nor approved by the FDA.\n<\/p>\n<p><b><span class=\"bwuline\">About Aditxt<\/span>:<\/b><\/p>\n<p>\nAditxt is developing technologies specifically focused on improving the health of the immune system through immune monitoring and reprogramming. Aditxt\u2019s immune monitoring technology is designed to provide a personalized comprehensive profile of the immune system. Aditxt\u2019s immune reprogramming technology is currently at the pre-clinical stage and is designed to retrain the immune system to induce tolerance with an objective of addressing rejection of transplanted organs, autoimmune diseases, and allergies. For more information, please visit: <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.aditxt.com&amp;esheet=52456046&amp;newsitemid=20210707005221&amp;lan=en-US&amp;anchor=www.aditxt.com&amp;index=4&amp;md5=63fc0ecb94f3b0feb3906a34c7397626\">www.aditxt.com<\/a><\/p>\n<p><b>Forward-Looking Statements<\/b><\/p>\n<p>\nCertain statements in this press release constitute \u201cforward-looking statements\u201d within the meaning of federal securities laws. Forward looking statements include statements regarding the Company\u2019s intentions, beliefs, projections, outlook, analyses or current expectations concerning, among other things, the Company\u2019s ongoing and planned product and business development; the Company\u2019s intellectual property position; the Company\u2019s ability to develop commercial functions; expectations regarding product launch and revenue; the Company\u2019s results of operations, cash needs, spending, financial condition, liquidity, prospects, growth and strategies; the industry in which the Company operates; and the trends that may affect the industry or the Company. Forward-looking statements are not guarantees of future performance and actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors, as well as those risks more fully discussed in the section titled \u201cRisk Factors\u201d in the Company\u2019s most recent Annual Report on Form 10-K, as well as discussions of potential risks, uncertainties, and other important factors in the Company\u2019s other filings with the Securities and Exchange Commission. All such statements speak only as of the date made, and the Company undertakes no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise.\n<\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210707005221r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\" \/><span class=\"bwct31415\" \/><\/p>\n<p id=\"mmgallerylink\"><span id=\"mmgallerylink-phrase\">View source version on businesswire.com: <\/span><span id=\"mmgallerylink-link\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20210707005221\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20210707005221\/en\/<\/a><\/span><\/p>\n<p>\nSunny Uberoi<br \/>\n<br \/>Chief Communications Officer<br \/>\n<br \/>Aditxt<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:ir@aditxt.com\">ir@aditxt.com<\/a><\/p>\n<p><b>KEYWORDS:<\/b> Virginia United States North America<\/p>\n<p><b>INDUSTRY KEYWORDS:<\/b> Biotechnology General Health Hospitals Health Pharmaceutical<\/p>\n<p><b>MEDIA:<\/b><\/p>\n<table cellpadding=\"3\" cellspacing=\"3\" \/>\n","protected":false},"excerpt":{"rendered":"<p>Aditxt Opens its First High-Capacity Immune Monitoring Center in Richmond, VA AditxtScoreTM Center to Become Global Headquarters for Aditxt as a Biotech Innovator Focused on Immune Health RICHMOND, Va.&#8211;(BUSINESS WIRE)&#8211;Aditxt, Inc. (Nasdaq: ADTX), a biotech innovation company with a mission to improve the health of the immune system, today announced the opening of its AditxtScore\u2122 Center in Richmond, VA. This high-capacity, CLIA-validated immune monitoring center will be scalable to process several million complex immune system reports per year. \u201cThe opening of the AditxtScore Center is a key step on AditxtScore\u2019s path to market, serving as a critical enabler to commercializing a new platform for personalized health,\u201d said Amro Albanna, Co-founder and Chief Executive Officer of Aditxt. \u201cIn addition to its &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/aditxt-opens-its-first-high-capacity-immune-monitoring-center-in-richmond-va\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Aditxt Opens its First High-Capacity Immune Monitoring Center in Richmond, VA&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-510164","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Aditxt Opens its First High-Capacity Immune Monitoring Center in Richmond, VA - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/aditxt-opens-its-first-high-capacity-immune-monitoring-center-in-richmond-va\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Aditxt Opens its First High-Capacity Immune Monitoring Center in Richmond, VA - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Aditxt Opens its First High-Capacity Immune Monitoring Center in Richmond, VA AditxtScoreTM Center to Become Global Headquarters for Aditxt as a Biotech Innovator Focused on Immune Health RICHMOND, Va.&#8211;(BUSINESS WIRE)&#8211;Aditxt, Inc. (Nasdaq: ADTX), a biotech innovation company with a mission to improve the health of the immune system, today announced the opening of its AditxtScore\u2122 Center in Richmond, VA. This high-capacity, CLIA-validated immune monitoring center will be scalable to process several million complex immune system reports per year. \u201cThe opening of the AditxtScore Center is a key step on AditxtScore\u2019s path to market, serving as a critical enabler to commercializing a new platform for personalized health,\u201d said Amro Albanna, Co-founder and Chief Executive Officer of Aditxt. \u201cIn addition to its &hellip; Continue reading &quot;Aditxt Opens its First High-Capacity Immune Monitoring Center in Richmond, VA&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/aditxt-opens-its-first-high-capacity-immune-monitoring-center-in-richmond-va\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-07-07T12:03:16+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210707005221r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aditxt-opens-its-first-high-capacity-immune-monitoring-center-in-richmond-va\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aditxt-opens-its-first-high-capacity-immune-monitoring-center-in-richmond-va\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Aditxt Opens its First High-Capacity Immune Monitoring Center in Richmond, VA\",\"datePublished\":\"2021-07-07T12:03:16+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aditxt-opens-its-first-high-capacity-immune-monitoring-center-in-richmond-va\\\/\"},\"wordCount\":622,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aditxt-opens-its-first-high-capacity-immune-monitoring-center-in-richmond-va\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210707005221r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aditxt-opens-its-first-high-capacity-immune-monitoring-center-in-richmond-va\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aditxt-opens-its-first-high-capacity-immune-monitoring-center-in-richmond-va\\\/\",\"name\":\"Aditxt Opens its First High-Capacity Immune Monitoring Center in Richmond, VA - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aditxt-opens-its-first-high-capacity-immune-monitoring-center-in-richmond-va\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aditxt-opens-its-first-high-capacity-immune-monitoring-center-in-richmond-va\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210707005221r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"datePublished\":\"2021-07-07T12:03:16+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aditxt-opens-its-first-high-capacity-immune-monitoring-center-in-richmond-va\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aditxt-opens-its-first-high-capacity-immune-monitoring-center-in-richmond-va\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aditxt-opens-its-first-high-capacity-immune-monitoring-center-in-richmond-va\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210707005221r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210707005221r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aditxt-opens-its-first-high-capacity-immune-monitoring-center-in-richmond-va\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Aditxt Opens its First High-Capacity Immune Monitoring Center in Richmond, VA\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Aditxt Opens its First High-Capacity Immune Monitoring Center in Richmond, VA - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/aditxt-opens-its-first-high-capacity-immune-monitoring-center-in-richmond-va\/","og_locale":"en_US","og_type":"article","og_title":"Aditxt Opens its First High-Capacity Immune Monitoring Center in Richmond, VA - Market Newsdesk","og_description":"Aditxt Opens its First High-Capacity Immune Monitoring Center in Richmond, VA AditxtScoreTM Center to Become Global Headquarters for Aditxt as a Biotech Innovator Focused on Immune Health RICHMOND, Va.&#8211;(BUSINESS WIRE)&#8211;Aditxt, Inc. (Nasdaq: ADTX), a biotech innovation company with a mission to improve the health of the immune system, today announced the opening of its AditxtScore\u2122 Center in Richmond, VA. This high-capacity, CLIA-validated immune monitoring center will be scalable to process several million complex immune system reports per year. \u201cThe opening of the AditxtScore Center is a key step on AditxtScore\u2019s path to market, serving as a critical enabler to commercializing a new platform for personalized health,\u201d said Amro Albanna, Co-founder and Chief Executive Officer of Aditxt. \u201cIn addition to its &hellip; Continue reading \"Aditxt Opens its First High-Capacity Immune Monitoring Center in Richmond, VA\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/aditxt-opens-its-first-high-capacity-immune-monitoring-center-in-richmond-va\/","og_site_name":"Market Newsdesk","article_published_time":"2021-07-07T12:03:16+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210707005221r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aditxt-opens-its-first-high-capacity-immune-monitoring-center-in-richmond-va\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aditxt-opens-its-first-high-capacity-immune-monitoring-center-in-richmond-va\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Aditxt Opens its First High-Capacity Immune Monitoring Center in Richmond, VA","datePublished":"2021-07-07T12:03:16+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aditxt-opens-its-first-high-capacity-immune-monitoring-center-in-richmond-va\/"},"wordCount":622,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aditxt-opens-its-first-high-capacity-immune-monitoring-center-in-richmond-va\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210707005221r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aditxt-opens-its-first-high-capacity-immune-monitoring-center-in-richmond-va\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/aditxt-opens-its-first-high-capacity-immune-monitoring-center-in-richmond-va\/","name":"Aditxt Opens its First High-Capacity Immune Monitoring Center in Richmond, VA - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aditxt-opens-its-first-high-capacity-immune-monitoring-center-in-richmond-va\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aditxt-opens-its-first-high-capacity-immune-monitoring-center-in-richmond-va\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210707005221r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","datePublished":"2021-07-07T12:03:16+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aditxt-opens-its-first-high-capacity-immune-monitoring-center-in-richmond-va\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/aditxt-opens-its-first-high-capacity-immune-monitoring-center-in-richmond-va\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aditxt-opens-its-first-high-capacity-immune-monitoring-center-in-richmond-va\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210707005221r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210707005221r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aditxt-opens-its-first-high-capacity-immune-monitoring-center-in-richmond-va\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Aditxt Opens its First High-Capacity Immune Monitoring Center in Richmond, VA"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/510164","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=510164"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/510164\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=510164"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=510164"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=510164"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}